CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Novartis commits $1.1B upfront to take Myricx Bio and its next-gen ADC platform

Positive
AI Analysis

Summary

Novartis announced an acquisition of Myricx Bio for $1.1 billion upfront to gain access to its next-generation ADC payload platform technology.

Importance:7/10
Sentiment:
0.60
M&AADCacquisitionplatform technology
Related Companies

Read the original article

Published by Endpoints News on July 6, 2026 10:46 AM

Read Original